188 related articles for article (PubMed ID: 35410461)
21. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
22. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication.
Orlandi C; Canovari B; Bozzano F; Marras F; Pasquini Z; Barchiesi F; De Maria A; Magnani M; Casabianca A
J Transl Med; 2020 May; 18(1):204. PubMed ID: 32429953
[TBL] [Abstract][Full Text] [Related]
23. Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
Chaillon A; Gianella S; Lada SM; Perez-Santiago J; Jordan P; Ignacio C; Karris M; Richman DD; Mehta SR; Little SJ; Wertheim JO; Smith DM
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142136
[TBL] [Abstract][Full Text] [Related]
24. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
[TBL] [Abstract][Full Text] [Related]
25. HIV, opioid use, and alterations to the gut microbiome: elucidating independent and synergistic effects.
Satish S; Abu Y; Gomez D; Kumar Dutta R; Roy S
Front Immunol; 2023; 14():1156862. PubMed ID: 37168868
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.
Sneller MC; Justement JS; Gittens KR; Petrone ME; Clarridge KE; Proschan MA; Kwan R; Shi V; Blazkova J; Refsland EW; Morris DE; Cohen KW; McElrath MJ; Xu R; Egan MA; Eldridge JH; Benko E; Kovacs C; Moir S; Chun TW; Fauci AS
Sci Transl Med; 2017 Dec; 9(419):. PubMed ID: 29212716
[TBL] [Abstract][Full Text] [Related]
27. HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers.
García M; Morcilla V; Navarrete-Muñoz MÁ; Fisher K; Cabello A; López-Bernaldo JC; De La Hera F; Barros C; Fernández-Guerrero M; Estrada V; Górgolas M; Benito JM; Palmer S; Rallón N
AIDS; 2021 Mar; 35(3):393-398. PubMed ID: 33252487
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a Novel Humanized Mouse Model To Investigate
Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
[TBL] [Abstract][Full Text] [Related]
29. Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features.
Bartsch YC; Loos C; Rossignol E; Fajnzylber JM; Yuan D; Avihingsanon A; Ubolyam S; Jupimai T; Hirschel B; Ananworanich J; Lauffenburger DA; Li JZ; Alter G; Julg B
mBio; 2021 Mar; 12(2):. PubMed ID: 33688003
[TBL] [Abstract][Full Text] [Related]
30. Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM.
Chen Y; Lin H; Cole M; Morris A; Martinson J; Mckay H; Mimiaga M; Margolick J; Fitch A; Methe B; Srinivas VR; Peddada S; Rinaldo CR
Microbiome; 2021 Dec; 9(1):237. PubMed ID: 34879869
[TBL] [Abstract][Full Text] [Related]
31. Fecal source identification using random forest.
Roguet A; Eren AM; Newton RJ; McLellan SL
Microbiome; 2018 Oct; 6(1):185. PubMed ID: 30336775
[TBL] [Abstract][Full Text] [Related]
32. Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers.
Vesterbacka J; Rivera J; Noyan K; Parera M; Neogi U; Calle M; Paredes R; Sönnerborg A; Noguera-Julian M; Nowak P
Sci Rep; 2017 Jul; 7(1):6269. PubMed ID: 28740260
[TBL] [Abstract][Full Text] [Related]
33. Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial.
Leth S; Schleimann MH; Nissen SK; Højen JF; Olesen R; Graversen ME; Jørgensen S; Kjær AS; Denton PW; Mørk A; Sommerfelt MA; Krogsgaard K; Østergaard L; Rasmussen TA; Tolstrup M; Søgaard OS
Lancet HIV; 2016 Oct; 3(10):e463-72. PubMed ID: 27658863
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Borgognone A; Elizalde-Torrent A; Casadellà M; Romero L; Escribà T; Parera M; Català-Moll F; Noguera-Julian M; Brander C; Olvera A; Paredes R
NPJ Biofilms Microbiomes; 2022 Dec; 8(1):104. PubMed ID: 36585401
[TBL] [Abstract][Full Text] [Related]
35. Effect of antiretroviral therapy on HIV reservoirs in elite controllers.
Chun TW; Shawn Justement J; Murray D; Kim CJ; Blazkova J; Hallahan CW; Benko E; Costiniuk CT; Kandel G; Ostrowski M; Kaul R; Moir S; Casazza JP; Koup RA; Kovacs C; Fauci AS
J Infect Dis; 2013 Nov; 208(9):1443-7. PubMed ID: 23847057
[TBL] [Abstract][Full Text] [Related]
36. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.
Boulassel MR; Chomont N; Pai NP; Gilmore N; Sékaly RP; Routy JP
J Clin Virol; 2012 Jan; 53(1):29-32. PubMed ID: 22019250
[TBL] [Abstract][Full Text] [Related]
37. Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine.
Ray S; Narayanan A; Giske CG; Neogi U; Sönnerborg A; Nowak P
ACS Infect Dis; 2021 May; 7(5):1104-1115. PubMed ID: 33346662
[TBL] [Abstract][Full Text] [Related]
38. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.
Chun TW; Justement JS; Murray D; Hallahan CW; Maenza J; Collier AC; Sheth PM; Kaul R; Ostrowski M; Moir S; Kovacs C; Fauci AS
AIDS; 2010 Nov; 24(18):2803-8. PubMed ID: 20962613
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).
Mothe B; Manzardo C; Sanchez-Bernabeu A; Coll P; Morón-López S; Puertas MC; Rosas-Umbert M; Cobarsi P; Escrig R; Perez-Alvarez N; Ruiz I; Rovira C; Meulbroek M; Crook A; Borthwick N; Wee EG; Yang H; Miró JM; Dorrell L; Clotet B; Martinez-Picado J; Brander C; Hanke T
EClinicalMedicine; 2019; 11():65-80. PubMed ID: 31312806
[TBL] [Abstract][Full Text] [Related]
40. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.
Serrano-Villar S; Rojo D; Martínez-Martínez M; Deusch S; Vázquez-Castellanos JF; Bargiela R; Sainz T; Vera M; Moreno S; Estrada V; Gosalbes MJ; Latorre A; Seifert J; Barbas C; Moya A; Ferrer M
EBioMedicine; 2016 Jun; 8():203-216. PubMed ID: 27428431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
